Gilead and Novo Nordisk announced new data from proof-of-concept trial in NASH
The FINANCIAL -- Gilead Sciences, Inc. and Novo Nordisk A/S announced results from a phase 2 proof-of-concept trial. The five-arm ...
The FINANCIAL -- Gilead Sciences, Inc. and Novo Nordisk A/S announced results from a phase 2 proof-of-concept trial. The five-arm ...